Produktbild: Anticancer Drug Development Guide

Anticancer Drug Development Guide

Lieferzeit: Lieferbar innerhalb 14 Tagen

106,99 €

inkl. 7 % MwSt. zzgl. Versandkosten

Preclinical Screening, Clinical Trials, and Approval, Cancer Drug Discovery and Development

ISBN: 1461581540
ISBN 13: 9781461581543
Herausgeber: Beverly A Teicher
Verlag: Humana Press
Umfang: xii, 311 S., 39 s/w Illustr., 311 p. 39 illus.
Erscheinungsdatum: 25.06.2013
Auflage: 1/2013
Produktform: Kartoniert
Einband: Kartoniert

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe in Dr. Beverly Teicher’s Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval the arduous process of cancer drug discovery and approval. The expert contributors focus on using in vivo and in vitro methods preclinically to identify molecules of interest, detailing the targets and criteria for success in each type of testing, and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval offers cancer researchers an authoritative survey rich in essential insight into the means and methods of cancer drug discovery and approval. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for present and future developments in the field.

Artikelnummer: 5903562 Kategorie:

Beschreibung

Herstellerkennzeichnung:


Humana Press in Springer Science + Business Media
Heidelberger Platz 3
14197 Berlin
DE

E-Mail: juergen.hartmann@springer.com

Das könnte Ihnen auch gefallen …